Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: Inhibition of Jak2 inactivates Lyn kinase

Blood Cancer Journal

Volumn 3, Issue 9, 2013, Pages

  Chakraborty, S ^a   Lin, Y H ^a   Leng, X ^a   Miranda, R N ^a   Medeiros, L J ^a   Shpall, E ^a   Arlinghaus, R B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; JANUS KINASE 2; N TERT BUTYL 3 [5 METHYL 2 [4 (4 METHYL 1 PIPERAZINYL)PHENYLAMINO] 4 PYRIMIDINYLAMINO]BENZENESULFONAMIDE; PROTEIN KINASE LYN;

BLAST CELL CRISIS; BLOOD CELL; CELL DEATH; CHRONIC MYELOID LEUKEMIA; ENZYME INHIBITION; HUMAN; LETTER; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84885335227     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.41     Document Type: Letter

References (6)

1. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876-880. (Pubitemid 32743979)
2. Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB et al. Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res 2004; 64: 672-677. (Pubitemid 38120909)
3. Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med 2004; 10: 1187-1189. (Pubitemid 39540433)
4. Samanta A, Perazzona B, Chakraborty S, Sun X, Modi H, Bhatia R et al. Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia 2011; 25: 463-472.
5. Samanta AK, Chakraborty S, Wang Y, Kantarjian H, Sun X, Hood J et al. Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients. Oncogene 2009; 28: 1669-1681.
6. Samanta AK, Lin H, Sun T, Kantarjian H, Arlinghaus RB. Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res 2006; 66: 6468-6472. (Pubitemid 44085597)